MBTPS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.30659999673244E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.475800E-03 |
Normal-vs-Stage2 |
3.56180000000705E-05 |
Normal-vs-Stage3 |
6.65030031044012E-10 |
Normal-vs-Stage4 |
6.18149975650795E-10 |
Stage1-vs-Stage2 |
1.031720E-02 |
Stage1-vs-Stage3 |
1.27289999996005E-06 |
Stage1-vs-Stage4 |
5.60869999999269E-07 |
Stage2-vs-Stage3 |
3.748400E-01 |
Stage2-vs-Stage4 |
1.440600E-01 |
Stage3-vs-Stage4 |
4.324600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.57370000048496E-08 |
Normal-vs-AfricanAmerican |
1.302990E-03 |
Normal-vs-Asian |
1.647980E-01 |
Caucasian-vs-AfricanAmerican |
6.520800E-01 |
Caucasian-vs-Asian |
7.568800E-01 |
AfricanAmerican-vs-Asian |
9.051200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.30230000117137E-08 |
Normal-vs-Female |
1.792050E-04 |
Male-vs-Female |
2.058000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.176400E-03 |
Normal-vs-Age(41-60Yrs) |
8.25790000000826E-05 |
Normal-vs-Age(61-80Yrs) |
2.91909999505791E-08 |
Normal-vs-Age(81-100Yrs) |
1.432820E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.651000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.602000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.535000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.849900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.892300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.290600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.662200E-01 |
Normal-vs-Grade 2 |
9.791500E-04 |
Normal-vs-Grade 3 |
2.29700000131672E-08 |
Normal-vs-Grade 4 |
1.12939657626043E-11 |
Grade 1-vs-Grade 2 |
5.888400E-02 |
Grade 1-vs-Grade 3 |
2.043300E-03 |
Grade 1-vs-Grade 4 |
7.3585000004428E-07 |
Grade 2-vs-Grade 3 |
7.164300E-04 |
Grade 2-vs-Grade 4 |
1.27279999873053E-08 |
Grade 3-vs-Grade 4 |
1.757130E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.717400E-03 |
Normal-vs-ccB subtype |
2.08349999997193E-06 |
ccA subtype-vs-ccB subtype |
4.097000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.60179999989063E-07 |
Normal-vs-N1 |
2.255100E-03 |
N0-vs-N1 |
3.079200E-01 |
|
|